BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24499657)

  • 1. Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer.
    Bodnar L; Stanczak A; Cierniak S; Smoter M; Cichowicz M; Kozlowski W; Szczylik C; Wieczorek M; Lamparska-Przybysz M
    J Ovarian Res; 2014 Feb; 7():16. PubMed ID: 24499657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.
    Nagy B; Tóth L; Molnár P; Méhes G; Thurzó L; Póka R; Hernádi Z
    Pathol Res Pract; 2017 Aug; 213(8):915-921. PubMed ID: 28651933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
    Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
    Kaltofen T; Preinfalk V; Schwertler S; Fraungruber P; Heidegger H; Vilsmaier T; Vattai A; Czogalla B; Mayr D; Mahner S; Jeschke U; Trillsch F
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2559-2574. PubMed ID: 32681294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of an altered Wnt1/β-catenin expression on clinicopathology and prognosis in clear cell renal cell carcinoma.
    Kruck S; Eyrich C; Scharpf M; Sievert KD; Fend F; Stenzl A; Bedke J
    Int J Mol Sci; 2013 May; 14(6):10944-57. PubMed ID: 23708097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
    Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
    Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.
    Huang KJ; Sui LH
    Med Oncol; 2012 Mar; 29(1):318-23. PubMed ID: 21264536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.
    Stanczak A; Stec R; Bodnar L; Olszewski W; Cichowicz M; Kozlowski W; Szczylik C; Pietrucha T; Wieczorek M; Lamparska-Przybysz M
    Pathol Oncol Res; 2011 Dec; 17(4):955-63. PubMed ID: 21678109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical significance of Wnt-1 and beta-catenin in nasopharyngeal carcinoma.
    Wang FL; Guo X; Yuan TZ; Cao SM; Rao HL; Hou JH; Shao Q; Li NW; Hong MH
    Ai Zheng; 2009 Jan; 28(1):72-5. PubMed ID: 19448422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer.
    Omichi C; Nakamura K; Haraga J; Masuyama H; Hiramatsu Y
    Cancer Med; 2016 Jun; 5(6):1074-80. PubMed ID: 26929186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
    Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
    Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines.
    Bodnar L; Stec R; Cierniak S; Synowiec A; Wcisło G; Jesiotr M; Koktysz R; Chrom P; Szczylik C
    Clin Genitourin Cancer; 2018 Aug; 16(4):257-265. PubMed ID: 29483043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.
    Ayed-Guerfali DB; Hassairi B; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
    Tumour Biol; 2014 Mar; 35(3):1775-83. PubMed ID: 24197976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.
    Liu M; Mor G; Cheng H; Xiang X; Hui P; Rutherford T; Yin G; Rimm DL; Holmberg J; Alvero A; Silasi DA
    Reprod Sci; 2013 May; 20(5):605-15. PubMed ID: 23171677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.